Learn More
Medchemexpress LLC 8-quinolinol, 7-[(2-benzothiazolylamino)[4-(difluoromethoxy)phenyl]methyl]- | 446826-86-4 | 98.1% (HPLC) | 449.47 g/mol | C24H17F2N3O2S | 5MG

Supplier: Medchemexpress LLC HY1238055MG
KIN1400 is a small-molecule research compound that functions as a potent IRF3 activator, inducing IRF3-dependent innate antiviral genes (RIG-I, MDA5, IFIT1, and Mx1) and increasing IFN-β expression. It has reported activity against West Nile virus, dengue virus, and hepatitis C virus, acting through a MAVS-IRF3 signaling axis and suitable for in vitro antiviral and innate immunity studies.
- Potent IRF3 activator that induces innate antiviral gene expression.
- Reported inhibition of WNV, DV, and HCV replication.
- Engages RIG-I and MDA5 pathways and elevates IFN-β levels.
- Small-molecule format intended for in vitro research applications.
- Molecular formula C24H17F2N3O2S; molecular weight 449.47 g/mol.
- Purity 98.1% (HPLC) as reported on batch certificate of analysis.
- Available in small research quantities suitable for assay development.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.